Monday, December 5, 2016

BRIEF-Eisai Inc announces final results of Phase 3 study of rufinamide

* Announced final results of its Phase 3 open-label two-year

study of rufinamide

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)